BDBM72234 2-(1H-Benzoimidazol-2-yl)-3-(4-difluoromethoxy-phenyl)-2-hydroxymethyl-propionitrile::2-(1H-benzimidazol-2-yl)-2-[4-(difluoromethoxy)benzyl]-3-hydroxy-propionitrile::2-(1H-benzimidazol-2-yl)-2-[[4-(difluoromethoxy)phenyl]methyl]-3-hydroxypropanenitrile::2-(1H-benzimidazol-2-yl)-2-[[4-[bis(fluoranyl)methoxy]phenyl]methyl]-3-oxidanyl-propanenitrile::MLS000589935::SMR000217231::cid_3797695

SMILES C[C@@H](NC(=O)c1cc(-c2ccnnc2)c(F)cc1NC1CCN(C)CC1)c1cccc(C(F)F)c1F

InChI Key InChIKey=NGTNZHVIXMUAJC-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72234   

TargetGTPase KRas [1-169,G12C](Human)
Schrodinger

US Patent
LigandChemical structure of BindingDB Monomer ID 72234BDBM72234((R)-N-(1-(3- (difluoromethyl)-2- fluorophenyl)ethy...)
Affinity DataIC50: 6.90nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2026
Entry Details
US Patent